Cheng Ean Chee
Overview
Explore the profile of Cheng Ean Chee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
664
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blasiak A, Truong A, Foo N, Tan L, Kumar K, Tan S, et al.
NPJ Precis Oncol
. 2025 Feb;
9(1):49.
PMID: 39984618
In oncology, the conventional reliance on the maximum tolerated dose (MTD) strategy for chemotherapy may not optimize treatment outcomes for individual patients. CURATE.AI is an AI-derived platform that utilizes a...
2.
Walsh R, Ong R, Cheo S, Low P, Jayagopal A, Lee M, et al.
Front Oncol
. 2024 May;
14():1342346.
PMID: 38812774
Introduction: Molecular profiling of metastatic breast cancer (MBC) through the widespread use of next-generation sequencing (NGS) has highlighted actionable mutations and driven trials of targeted therapy matched to tumour molecular...
3.
Chee C, Khara J, Cheong J, Fong J, Sivanesan S, Choy J, et al.
Expert Rev Pharmacoecon Outcomes Res
. 2024 May;
24(5):631-641.
PMID: 38776431
Objectives: This study aims to explore the cost-effectiveness of atezolizumab plus bevacizumab against sorafenib for first-line treatment of locally advanced or metastatic hepatocellular carcinoma (HCC) in Singapore. Methods: A partitioned...
4.
Pathak P, Chan G, Deming D, Chee C
Am Soc Clin Oncol Educ Book
. 2024 May;
44(3):e438466.
PMID: 38768405
Colorectal cancer (CRC) remains a significant global health challenge, ranking among the leading causes of cancer-related morbidity and mortality worldwide. Recent advancements in molecular characterization have revolutionized our understanding of...
5.
Mendis S, Lipton L, To Y, Ananda S, Michael M, McLachlan S, et al.
Br J Cancer
. 2024 Mar;
130(9):1477-1484.
PMID: 38448752
Background: Pancreatic cancer incidence is increasing in younger populations. Differences between early onset pancreatic cancer (EOPC) and later onset pancreatic cancer (LOPC), and how these should inform management warrant exploration...
6.
Johnson D, Chee C, Wong W, Lam R, Tan I, Ma B
Cancer Treat Rev
. 2024 Feb;
125:102700.
PMID: 38422896
The last two decades have witnessed major breakthroughs in the development of targeted therapy for patients with metastatic colorectal cancer (mCRC), an achievement which stems largely from advances in translational...
7.
Jen W, Chan Z, Lee Y, Ng N, Tan B, Teo C, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760594
Introduction: Chemotherapy is complex. We hypothesized that a design thinking approach could redesign preparatory processes and reduce wait times. Methods: A multidisciplinary process mapping exercise was undertaken to understand the...
8.
Catenacci D, Kang Y, Uronis H, Lee K, Ng M, Enzinger P, et al.
Oncology (Williston Park)
. 2023 Apr;
37(4):176-183.
PMID: 37104758
Purpose: To assess the ability of circulating tumor DNA (ctDNA)-based testing to identify patients with HER2 (encoded by ERBB2)-positive gastric/gastroesophageal adenocarcinoma (GEA) who progressed on or after trastuzumab-containing treatments were...
9.
Choo J, Kua L, Soe M, Asuncion B, Tan B, Teo C, et al.
Gastric Cancer
. 2023 Feb;
26(3):393-404.
PMID: 36781556
Background: We evaluated the relevance of PD-1CD8 T-cells in gastric cancer (GC) including prognostic significance, association with chemotherapy and immunotherapy sensitivity and correlations with the tumor microenvironment (TME). Methods: Discovery...
10.
Lee M, Peng S, Lee A, Wong S, Tay R, Li J, et al.
Ann Acad Med Singap
. 2023 Feb;
52(1):8-16.
PMID: 36730801
Introduction: Three doses of SARS-CoV-2 mRNA vaccines have been recommended for cancer patients to reduce the risk of severe disease. Anti-neoplastic treatment, such as chemotherapy, may affect long-term vaccine immunogenicity....